LAP2 (Lamina-associated polypeptide 2) inhibitors represent a class of compounds that target a specific protein involved in the structural organization of the cell nucleus. LAP2 is a integral membrane protein localized in the inner nuclear membrane, playing a crucial role in maintaining nuclear architecture and regulating various cellular processes. The inhibition of LAP2 involves disrupting its normal function, which in turn affects the structural integrity and organization of the nuclear envelope. This class of inhibitors typically interacts with LAP2 through various mechanisms, such as binding to specific domains of the protein or modulating its post-translational modifications. By interfering with LAP2, these inhibitors influence the interactions between chromatin and the nuclear envelope, potentially impacting essential cellular functions.LAP2 inhibitors vary widely, encompassing small molecules and peptides designed to selectively target LAP2.
The design and development of LAP2 inhibitors often involve a deep understanding of the protein's structure and function. Researchers explore diverse chemical structures and modes of binding to optimize the inhibitory effects while minimizing off-target interactions. The ultimate goal is to elucidate the precise molecular interactions that lead to LAP2 inhibition, enabling the design of potent and selective compounds. Continued research in this chemical class holds promise for advancing our understanding of nuclear envelope dynamics and may have implications for various cellular processes influenced by LAP2 function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Inhibits HMG-CoA reductase, which can reduce prelamin A levels and thus indirectly affect LAP2. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Also an HMG-CoA reductase inhibitor, it can indirectly affect LAP2 by reducing prelamin A levels. | ||||||
Pravastatin | 81093-37-0 | sc-222188 | 50 mg | $408.00 | 1 | |
Pravastatin is another HMG-CoA reductase inhibitor, impacting LAP2 functionality indirectly. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $77.00 $179.00 | 18 | |
By inhibiting HMG-CoA reductase, mevastatin can indirectly influence LAP2 function. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane induces the nuclear export of LAP2, thereby indirectly inhibiting its function in the nucleus. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
ATRA can induce LAP2 phosphorylation, thus indirectly inhibiting its function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can indirectly affect LAP2 function by altering protein degradation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine affects lysosomal function, which can indirectly influence LAP2 function by disrupting protein degradation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase that may indirectly influence LAP2 function. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin can modulate AMPK activity, which can indirectly impact LAP2 function. | ||||||